Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-12 Purchase | 2023-05-16 4:05 pm | CHIMERIX INC | CMRX | Sherman Michael A. Chief Executive Officer | 87,000 | $1.1224 | $97,652 | 423,408 (Indirect Direct) | View |
| 2020-03-12 Purchase | 2020-03-16 12:51 pm | CHIMERIX INC | CMRX | Sherman Michael A. Chief Executive Officer | 72,995 | $1.4474 | $105,653 | 107,685 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-20 Option Award | 2024-06-21 11:05 am | N/A 2034-06-19 | CHIMERIX INC | CMRX | Sherman Michael A. Chief Executive Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-24 7:45 pm | N/A 2034-05-23 | Werewolf Therapeutics Inc. | HOWL | Sherman Michael A. Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:48 pm | N/A 2033-06-20 | Werewolf Therapeutics Inc. | HOWL | Sherman Michael A. Director | 13,200 | $0 | 13,200 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-19 9:46 pm | N/A 2033-01-16 | CHIMERIX INC | CMRX | Sherman Michael A. Chief Executive Officer | 650,000 | $0 | 883,040 (Direct) | View |
| 2022-07-25 Exercise(A) | 2022-07-27 1:46 pm | N/A 2029-04-07 | CHIMERIX INC | CMRX | Sherman Michael A. Chief Executive Officer | 100,000 | $0 | 1,378,359 (Direct) | View |
| 2022-07-25 Exercise(A) | 2022-07-27 1:46 pm | N/A N/A | CHIMERIX INC | CMRX | Sherman Michael A. Chief Executive Officer | 100,000 | $2.09 | 1,378,359 (Direct) | View |
| 2022-07-25 Exercise | 2022-07-26 9:25 pm | N/A 2029-04-07 | CHIMERIX INC | CMRX | Sherman Michael A. Chief Executive Officer | 100,000 | $0 | 1,275,364 (Direct) | View |
| 2022-07-25 Exercise | 2022-07-26 9:25 pm | N/A N/A | CHIMERIX INC | CMRX | Sherman Michael A. Chief Executive Officer | 100,000 | $2.09 | 1,275,364 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:39 pm | N/A 2032-05-31 | Werewolf Therapeutics Inc. | HOWL | Sherman Michael A. Director | 11,600 | $0 | 11,600 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 6:53 pm | N/A 2032-01-17 | CHIMERIX INC | CMRX | Sherman Michael A. Chief Executive Officer | 875,000 | $0 | 875,000 (Direct) | View |
| 2021-05-27 Option Award | 2021-05-28 08:07 am | N/A 2031-05-26 | Werewolf Therapeutics Inc. | HOWL | Sherman Michael A. Director | 23,200 | $0 | 23,200 (Direct) | View |
| 2021-01-22 Option Award | 2021-01-26 4:40 pm | N/A 2031-01-21 | CHIMERIX INC | CMRX | Sherman Michael A. Chief Executive Officer | 700,000 | $0 | 700,000 (Direct) | View |
| 2020-12-02 Disposition | 2020-12-02 09:45 am | N/A N/A | BIOSPECIFICS TECHNOLOGIES CORP | BSTC | Sherman Michael A. Director | 2,018 | $0 | 0 (Direct) | View |
| 2020-12-02 Disposition | 2020-12-02 09:45 am | N/A 2030-05-01 | BIOSPECIFICS TECHNOLOGIES CORP | BSTC | Sherman Michael A. Director | 6,000 | $32.87 | 0 (Direct) | View |
| 2020-05-01 Option Award | 2020-05-04 6:21 pm | N/A 2030-05-01 | BIOSPECIFICS TECHNOLOGIES CORP | BSTC | Sherman Michael A. Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2020-04-13 Option Award | 2020-04-15 2:28 pm | N/A N/A | BIOSPECIFICS TECHNOLOGIES CORP | BSTC | Sherman Michael A. Director | 2,018 | $0 | 2,018 (Direct) | View |
| 2020-01-21 Option Award | 2020-01-23 4:32 pm | N/A 2030-01-20 | CHIMERIX INC | CMRX | Sherman Michael A. Chief Executive Officer | 632,500 | $0 | 632,500 (Direct) | View |